title: Comment on research report by Gruson and colleagues, this issue.
authors: Carol Ann
authors: CA
authors: Huff
authors: Ingemar S J
authors: IS
authors: Merkies
authors: Richard A C
authors: RA
authors: Hughes
authors: David R
authors: DR
authors: Cornblath
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008297:Male; D011129:Polyradiculoneuropathy / Q000188:drug therapy*; D000069283:Rituximab; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D014740:Vidarabine; C024352:fludarabine